Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › RPGLIFE

RPGLIFE

RPG Life Sciences Limited
Micro-capPharma ↗

What the six lenses say about RPGLIFE — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹2673.4
2026-09-08
VWAP · 1Y anchor
₹2353
+13.6% from VWAP
P/E · TTM
21.4×
TTM EPS ₹124.7
52-week range
73%
position low→high
RSI(14)
52
momentum

Own sector index

Pharma ↗
Overweight

1M

+0.4%

3M

+10.5%

1Y

+22.0%

Breadth >EMA21

56%

How RPGLIFE’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
6.5
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Micro-cap cohortDRaw
TechnicalD995›

The actual numbers

Price vs VWAP (1y)+13.6%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+12.7%
Price vs 50-EMA+2.3%
RSI(14)52
RS vs Nifty 500 · 3M+23.5%
RS vs sector · 3M+17.5%
52-week range73%
Volume vs 30d avg1.79×
Volume vs 60d avg1.06×
ATR(14) · volatility122.3
Bollinger width · vol contraction0.092
FundamentalD859›

The actual numbers

Return on equity (ROE)34.0%
Operating margin37.1%
Net margin30.2%
Revenue growth · YoY+7.0%
EPS growth · YoY+160.6%
Debt / equity0.03×

Full 8-quarter history in the financials table below.

ValuationD745›

The actual numbers

P/E (TTM)21.4×
TTM EPS₹124.7
52-week range73%
CatalystD639›

The actual numbers

Earnings & momentum48
Capital actions6
Governance74

Every filing in the corporate-announcements panel below.

FlowD450›

The actual numbers

Promoter holding73.0%
Delivery · 30d avg48.7%
Up/down-day asymmetry-1.1pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D9 + D4 ) ÷ 2 = 6.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
91
Conviction score 91/100 · avg-decile strength 6.5/10
Conviction score91/100›
TechnicalD9›
FundamentalD8›
ValuationD7›
CatalystD6›
FlowD4›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
-1.3pp
+2.9pp
+2.9pp
+25.1pp
+45.5pp
+16.7pp
Nifty 500
Broad-market baseline
-1.3pp
+2.9pp
+1.8pp
+23.5pp
+39.8pp
+11.4pp
Sector
Own-sector index
—
—
-1.0pp
+17.5pp
+26.7pp
-9.3pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

RPGLIFE daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
2673.40-48.20

Relative strength

RS vs baseline · rebased to 100

RPGLIFE ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
114.08-1.57

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricDec '24Mar '25Sep '25Dec '25Mar '26
Revenue (₹cr)173143182180177
↳ change QoQ—-17.3%+27.3%-1.1%-1.7%
EBITDA (₹cr)4925394033
EBITDA margin28.3%17.5%21.4%22.2%18.6%
PAT (₹cr)35117372230
↳ change QoQ—+234.3%-68.4%-40.5%+36.4%
Net margin20.2%81.8%20.3%12.2%17.0%
EPS (₹)21.1270.9522.2813.3818.08
D/E—————
YoY growth · Mar '26Revenue +2.3% YoYPAT -14.3% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 9 Sep '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 4 Sep '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 3 Sep '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 2 Sep '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 2 Sep '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 2 Sep '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 2 Sep '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 2 Sep '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 1 Sep '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 20 Aug '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 15 Aug '26
    MEDIUMgovernance
    Resignation of Director/KMP/SMP
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 15 Aug '26
    MEDIUMgovernance
    Cessation
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 15 Aug '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 15 Aug '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds RPGLIFE

Mutual funds holding RPGLIFE (1)

FundWeightAUM ₹crGrade
Unifi Flexi Cap Reg Gr0.80%227

ETFs holding RPGLIFE (0)

No tracked ETF holds RPGLIFE ≥0.5%.

Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma